IDEAYA Biosciences, Inc.
USD27.87
-1.07 (-3.70%)
CEO
Yujiro S. Hata
IPO Date
2019-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$28.58
Prev. Close
$28.94
Day Low
$27.78
Day High
$28.84
52W Low
$20.45
52W High
$39.28
Market Cap
$2.45B
Volume
0.79M
| 170,000 |
| $32.19 |
| 2 Feb 2026 | WHITE MICHAEL ANTHONY | Chief Scientific Officer | A-Award | Acquired | 190,000 | $32.19 |
| 2 Feb 2026 | Beaupre Darrin | Chief Medical Officer | A-Award | Acquired | 175,000 | $32.19 |
| 2 Feb 2026 | DORMAN STUART | Chief Commercial Officer | A-Award | Acquired | 155,000 | $32.19 |
| 2 Feb 2026 | Hata Yujiro S | director, officer: President and CEO | A-Award | Acquired | 600,000 | $32.19 |
| 2 Feb 2026 | Snyder Douglas B. | SVP, General Counsel | A-Award | Acquired | 1,041 | $16.91 |
| 2 Feb 2026 | Snyder Douglas B. | SVP, General Counsel | A-Award | Acquired | 1,039 | $16.91 |
| 2 Feb 2026 | Snyder Douglas B. | SVP, General Counsel | A-Award | Acquired | 130,000 | $32.19 |
| 2 Feb 2026 | Ruiz Briseno Andres | See Remarks | A-Award | Acquired | 80,000 | $32.19 |